HELLP-syndrome as a variant of renal thromboticmicroangiopathy


Cite item

Full Text

References

  1. Sibai В. М., Kustermann L., Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, HELLP syndrome and postpartum acute renal failure: different clinical syndromes or just different names? Curr. Opin. Nephrol. Hypertens. 1994; 3 (4): 436-445.
  2. Nochy D., Daugas E., Droz D. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J. Am. Soc. Nephrol. 1999; 10 (2): 507-518.
  3. Nicholls K., Kincaid-Smith P. Antiphospholipid syndrome and renal thrombotic microangiopathy. J. Nephrol. 1995: 8 (3): 123-125.
  4. Sibai В. М., Taslimi M. Maternal-perinatal outcome associated with syndrome of hemolysis, elevated liver enzymes and low platelets. Am. J. Obstet. Gynecol. 1986; 155 (3): 501-509.
  5. Jones S. L. HELLP. A cry for laboratory assistance. Hematopathol. Mol. Hematol. 1998; 11 (3-4): 147-171.
  6. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelets count. Am. J. Obstet. Gynecol. 1982: 142 (1): 159-169.
  7. Sibai B. M., Ramadan M. K. Maternal morbidity and mortality in 442 pregnancies with HELLP syndrome. Ibid. 1993: 169 (5): 1000-10061006.
  8. Friedman S. A. Preeclampsia: a review of the role of prostaglandins. Obstet. and Gynecol. 1988; 71 (1): 122-137.
  9. Scott J. R. The HELLP syndrome. In: Disaia P., Hammond С. В., eds. Obstetrics and Gynecology. 7"' ed. Philadelphia: Lippincott; 1994. 351-365.
  10. Geary M. The HELLP syndrome. Br. J. Obstet. Gynaecol. 1997; 104 (8): 887-891.
  11. Seligman S. P., Buyon J. P., Clancy R. M. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 1994; 171 (4): 944-948.
  12. Lyall I. A., Greer F., Boswell L. M. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia. Br. J. Obstet. Gynaecol. 1994; 101 (3): 485-487.
  13. Branch D. W., Andres R., Digre К В. The association of antiphospholipid antibodies with severe preeclampsia. Obstet and Gynecol. 1989; 73 (4): 541-545.
  14. Polzin W. J., Kopelman J. N., Robinson R. D. Antiphospholipid antibodies and HELLP syndrome. Ibid. 1991; 78 (8): 1108-1111.
  15. El-Roeiy A., Gleisher N. Detection of antiphospholipid antibodies in the sera of patients with preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol. 1991; 164 (6): 1253-1261.
  16. Amant F., Spitz В., Amout J. Hepatic necrosis and haemorrhage in pregnant patients with antiphospholipid antibodies. Lupus 1997; 6 (6): 552-555.
  17. Asherson R. A., Kant К. Sh. Antiphospholipid antibodies and the kidney. J. Rheumatol. 1993; 20 (8): 1268-1272.
  18. Knapen M. F., van Altena A. M., Peters V. H. Liver function following pregnancy complicated by the HELLP-syndrome.Br. J. Obstet. Gynaecol. 1998; 105 (12): 1208-1210.
  19. Treem W. R., Shoup M. E., Bennet M. G. Acute fatty liver in pregnancy, hemolysis, elevated liver enzymes and low platelets syndrome and long chain 3-hydroxyacyl-coenzymeA dehydrogenase deficiency. Am. J. Gastroenterol. 1996; 91 (11): 2293- 2300.
  20. Brenner В., Lanir N., Thaler I. HELLP syndrome associated with factor V R506Q mutation. Br. J. Haematol. 1996; 92 (4): 999-1001.
  21. Kolben M., Lopens A., Blaser J. Proteases and their inhibitors are indicative in gestational disease. Eur. J. Obstet. Gynaecol. Reprod. Biol. 1996; 68 (1-2): 59-65.
  22. Шамара М. А., Шулутко Е. M., Бирюкова Л. С. HELLP- синдром. Пробл. гематол. 2001; 1: 41-52.
  23. Smith L. G., Moise K. J. Spontaneous rupture of liver during pregnancy: current therapy. Ibid. 1991; 77 (2): 171 - 175.
  24. Risseeuw J. J., de Vries J. E., van Eyck J. Liver rupture postpartum associated with preeclampsia and HELLP syndrome. J. Maternal-Fetal Med. 1999; 8 (1): 32-35.
  25. Суров А. В. HELLP-синдром в акушерстве. Акуш. и гин. 1997; 6: 7-8.
  26. Martin J. N.. Blake P. G. The natural history of HELLP syndrome. Am. J. Obstet. Gynecol. 1991; 164 (6): 1500-1513.
  27. Neuman M., Ron E. R., Longer R. Maternal death caused by HELLP syndrome with hypoglycemia. Ibid. 1990; 162 (2): 372-373.
  28. Kurzel R. В., An A. H., Rooholomini S. A. Doppler velocimetry of hepatic blood flow in postpartum patients with HELLP-syndrome. Ibid. 1996; 175 (6): 1677-1678.
  29. Fang J.-Т., Chen Y.-C. Unusual presentation of mesangial proliferative glomerulonephritis in HELLP syndrome associated with acute renal failure. Renal Failure 2000; 22 (5): 641-646.
  30. Козловская Н. Л., Тареева И. Е., Варшавский В. А. Поражение почек при первичном антифосфолипидном синдроме. Тер. арх.2001; 6: 26-30.
  31. Selcuk N. У., Odabas A. R., Getinkaya R. Outcome of pregnancies with HELLP syndrome complicated by acute renal failure. Renal Failure. 2000; 22 (3): 319-327.
  32. Ghosh A. K., Vanhisht K., Varma S. Acute renal failure in a ptient with HELLP syndrome. Ibid. 1994; 16 (2): 295-298.
  33. Pandya K., Djabetey E., Hankin T. The Preeclampsia, Pulmonary Oedema, Cardiomyopathy Syndrome (PPOCS). Int. J. Obstet. Anesth. 1999; 8 (3): 195-196.
  34. Nishikawa K., Sato H. Peripartum cardiomyopathy presenting after Caesarean section. Eur. J. Anaesth. 1999; 16 (1): 130- 132.
  35. West P., Keogh A. Peripartum cardiomyopathy. A review of 22 patients. Austr. N. Z. J. Med. 1993; 23 (1): 81-82.
  36. Suresh M. S. HELLP syndrome: an anesthesiologists perspectives. Am. J. Obstet. Gynecol. 1996; 175 (1): 101-103.
  37. Рогов В. А., Гордовская Н. Б. Почки и беременность. В кн.:Тареева И. Е. (ред.) Нефрология. М.; 2000. 464-483.
  38. Cheek Т. G., Samuels P. Pregnancy-induced hypertension. In:Data S., ed. Anesthetic and obstetric management of high-risk pregnancy. St. Louis: Mosby; 1996. 386-412.
  39. Nod M., Friedman S., Schoenfeld A. Hydralazine-induced hepatitis in pregnancy. Int. J. Fertil. 1986; 31 (3): 352-355.
  40. Bick R. L. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy and gynecology. Objective criteria for diagnosis and management. Hematol. Oncol. Clin. N. Am. 2000; 14: 999-1044.
  41. Sibai В. M. Prevention of preeclampsia with low dose aspirin.N. Engl. J. Med. 1993; 329 (6): 1213-1218.
  42. De Belder A., Martin J., Moncado S. Treatment of HELLP syndrome with nitric oxide donor. Lancet, 1995; 345: 124- 125.
  43. Martin J. N., Files J. S., Blake P. G. Postpartum plasma exchange for atypical preeclampsia/eclampsia as HELLP. Am. J. Obstet. Gynecol. 1995; 172 (5): 1107-1127.
  44. Martin J. N., Perry K. G., Blake P. G. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP. Ibid. 1997; 177(4): 1011-1017.
  45. Magann E. F., Martin R. W., Isaacs J. D. Corticosteroids for the enchancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome. Aust. N. Z. J. Obstet. Gynecol. 1993; 33 (1): 127-131.
  46. Громыко Г. Л. Роль антифосфолипидного синдрома в развитии акушерских осложнений. Пробл. репрод. 1997; 4: 13-18.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies